NCT Number: NCT01964703
Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes
The purpose of this study is to determine whether Rubus occidentalis extract could improve fasting or postprandial serum glucose levels, and related metabolic markers among patients with prediabetes (impaired fasting glucose and/or impaired glucose tolerance).
Looking for future studies?
Notify MeKey information
Conditions
Age range
19 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 19 years of age or older
- prediabetes (fasting plasma glucose 100-125mg/dl, and/or post 75g OGTT plasma glucose 140-199mg/dl)
Exclusion criteria
- pregnant women
- taking anti-hyperglycemic agents within 3 months at the time of enrollment
- history of heart failure, myocardial infarction, cerebral infarction
- uncontrolled hypertension (systolic BP > 160mmHg, or diastolic BP > 100mmHg)
- serum triglyceride level > 500mg/dl
- kidney dysfunction (serum Creatinine > 30% of upper normal limits)
- hepatic dysfunction (AST, ALT > 3 times of upper normal limits)
- taking systemic glucocorticoids within 1 month
Treatment and study plan
Primary outcomes
-
serum glucose (fasting and post 75g oral glucose tolerance test)
Time frame: 12 weeks
Secondary outcomes
-
serum insulin
Time frame: 12 weeks
Other outcomes
-
HOMA IR, QUICKI, HOMA beta, lipid profile, inflammatory markers
Time frame: 12 weeks
Sponsors and collaborators
Lead sponsor
Korea University Anam Hospital
Other
Registry information
Official study title
Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes; A Proof-of-concept, Randomized, Double-blind, Parallel-group Placebo-controlled Study
Important dates
- Study start
- 2013
- Primary completion
- 2013
- First posted
- Oct 17, 2013
- Registry last updated
- Oct 17, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Diabetes Prevention Program Outcomes Study
NCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial DetailsPersonalized Meal Timing and Walking Based on Glucose Patterns in Adults With Prediabetes
NCT07618663
Diabetes Mellitus, Endocrine System Diseases
Lahore, Shaikhupura, Pakistan
View Trial DetailsmHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes
NCT05351359
Diabetes Mellitus, Diabetes Mellitus, Type 2
Prague, Czechia
View Trial DetailsThe Effects of Intermittent Fasting on Anthropometric Measurements and Metabolic Parameters in Prediabetic Patients
NCT07713394
Behavior, Body Weight
Erzurum, Turkey, Turkey (Türkiye)
View Trial Details